| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10010545 | HBV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS10010546 | HBV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS10011227 | HBV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS10044642 | HBV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS10044643 | HBV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS10042159 | HBV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS10042160 | HBV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS10057422 | HBV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS30079620 | HIV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
| TVIS30081725 | HIV | ENSG00000153904.21 | protein_coding | DDAH1 | No | No | 23576 | B1AKK2 B4DYP1 O94760 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | DDAH1 |
|---|---|
| DrugBank ID | DB00155 |
| Drug Name | Citrulline |
| Target ID | BE0000766 |
| UniProt ID | O94760 |
| Regulation Type | |
| PubMed IDs | 14766200; 10950934; 12615801 |
| Citations | Mishima T, Hamada T, Ui-Tei K, Takahashi F, Miyata Y, Imaki J, Suzuki H, Yamashita K: Expression of DDAH1 in chick and rat embryos. Brain Res Dev Brain Res. 2004 Feb 20;148(2):223-32.@@Tran CT, Fox MF, Vallance P, Leiper JM: Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins. Genomics. 2000 Aug 15;68(1):101-5.@@Arrigoni FI, Vallance P, Haworth SG, Leiper JM: Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia. Circulation. 2003 Mar 4;107(8):1195-201. |
| Groups | Investigational; Nutraceutical |
| Direct Classification | L-alpha-amino acids |
| SMILES | N[C@@H](CCCNC(N)=O)C(O)=O |
| Pathways | Citrullinemia Type I; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Argininemia; Hyperornithinemia with Gyrate Atrophy (HOGA); Canavan Disease; Hypoacetylaspartia; Hyperprolinemia Type II; Argininosuccinic Aciduria; L-Arginine:Glycine Amidinotransferase Deficiency; Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]; Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency); Prolidase Deficiency (PD); Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency; Carbamoyl Phosphate Synthetase Deficiency; Ornithine Aminotransferase Deficiency (OAT Deficiency); Hyperprolinemia Type I; Aspartate Metabolism; Nitric Oxide Signaling Pathway; Arginine and Proline Metabolism; Ornithine Transcarbamylase Deficiency (OTC Deficiency); Prolinemia Type II; Urea Cycle |
| PharmGKB | PA164747225 |
| ChEMBL | CHEMBL444814 |
